1031P Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
| Autor: | Babiker, H., Borazanci, E., Subbiah, V., Algazi, A.P., Schachter, J., Lotem, M., Hendler, D., Rahimian, S., Minderman, H., Haymaker, C., Bernatchez, C., Murthy, R., Hultsch, R., Caplan, N., Woodhead, G.J., Hennemeyer, C.T., Chunduru, S., Anderson, P., Diab, A., Puzanov, I. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S711-S712 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|